Kinaxo Biotechnologies

Kinaxo is developing chemical proteomics methods for small molecule drug development

History:

Kinaxo was acquired by Evotec in 2011.

Employment

Email:

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:
Europe

Research Focus:
Proteomics Disease Therapeutics-Research Therapeutics-Development

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: